Corifollitropin Alfa Versus Recombinant Follicle Stimulating Hormone (FSH) in Ovarian Stimulation of Women Undergoing in Vitro Fertilisation
Launched by NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS · Mar 21, 2011
Trial Information
Current as of July 24, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women aged 18-36 years old with a body weight of more than 60 kg up to 90 kg
- • BMI of 18-32 kg/m2
- • Menstrual cycle length of 23-35 days
- • An indication for controlled ovarian stimulation for IVF or ICSI
- Exclusion Criteria:
- • history of an endocrine abnormality
- • abnormal outcome of blood biochemistry or hematology
- • abnormal cervical smear
- • chronic disease
- • uterine pathology that interfering with the COS treatment (e.g. fibroids ≥ 5 cm)
About National And Kapodistrian University Of Athens
The National and Kapodistrian University of Athens is a prestigious academic institution in Greece, renowned for its commitment to advancing medical research and education. With a strong emphasis on interdisciplinary collaboration, the university fosters innovative clinical trials aimed at improving healthcare outcomes. Its dedicated research teams leverage cutting-edge methodologies and a diverse range of expertise to address critical health challenges. As a clinical trial sponsor, the university prioritizes ethical standards and the welfare of participants, contributing significantly to the global body of medical knowledge and the development of new therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Athens, Chaidari, Greece
Athens, Chaidari, Greece
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials